|
Bayer HealthCare Pharmaceuticals has its roots in radiology. The commitment to imaging began over 75 years ago when its parent company became a contrast media manufacturer. With such a foundation, Bayer HealthCare Pharmaceuticals has established a long tradition of bringing high quality, innovative imaging products to the healthcare marketplace.
Over the years, our products have helped revolutionize imaging technology. They include introduction of MAGNEVIST® the first paramagnetic MRI contrast agent, ULTRAVIST® a world-class x-ray agent, and FERIDEX I.V.® the first liver-specific MRI contrast agent. The Bayer HealthCare Pharmaceuticals imaging product line has been built on searching out new technologies through acquisitions as well as alliances and partnerships. With its Accrual Program, Bayer HealthCare Pharmaceuticals has partnered with the industry's leading hardware and software manufacturers to help customers acquire the CT and MR products and services they need to help enhance their clinical performance and bring efficiencies to their business.
- Only Bayer HealthCare Pharmaceuticals offers access to as wide and varied a list of world-class partners such as Siemens, Medrad, MRI Devices Corporation, Philips, and E-Z-EM.
- Partnering with sister company, Medrad, a world leader in vascular injection systems and MR surface coils
- Forming an alliance with Hospira, Inc. to increase diagnostic imaging distribution capabilities
- FERIDEX I.V.® (ferumoxides injectable solution) which is a registered trademark of Advanced Magnetics Inc.
As a leader in the field, Bayer HealthCare Pharmaceuticals continually strives to satisfy the demand for new diagnostic and therapeutic agents. Our goal is to give clinicians everything they need to see by bringing high quality products to market supported by extensive professional and technical education programs.
|
